|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 102 for Ucn2

<< First    < Previous  |  Next >    Last >>
0.042s
Type Details Score
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: dog, domestic
Gene
Type: gene
Organism: chimpanzee
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: rat
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Publication
First Author: Flaherty SE 3rd
Year: 2023
Journal: Nat Commun
Title: Chronic UCN2 treatment desensitizes CRHR2 and improves insulin sensitivity.
Volume: 14
Issue: 1
Pages: 3953
Publication
First Author: Breu J
Year: 2012
Journal: Behav Brain Res
Title: Urocortin 2 modulates aspects of social behaviour in mice.
Volume: 233
Issue: 2
Pages: 331-6
Publication
First Author: Voltolini C
Year: 2015
Journal: Endocrinology
Title: Urocortin 2 role in placental and myometrial inflammatory mechanisms at parturition.
Volume: 156
Issue: 2
Pages: 670-9
Publication
First Author: Tillinger A
Year: 2013
Journal: J Neurochem
Title: Stress-induced changes in gene expression of urocortin 2 and other CRH peptides in rat adrenal medulla: involvement of glucocorticoids.
Volume: 125
Issue: 2
Pages: 185-92
Publication
First Author: Hao Z
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation.
Volume: 105
Issue: 10
Pages: 3939-44
Publication
First Author: Gao MH
Year: 2016
Journal: JCI Insight
Title: One-time injection of AAV8 encoding urocortin 2 provides long-term resolution of insulin resistance.
Volume: 1
Issue: 15
Pages: e88322
Publication
First Author: Tsatsanis C
Year: 2006
Journal: J Immunol
Title: Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1.
Volume: 176
Issue: 3
Pages: 1869-77
Publication  
First Author: Zhu C
Year: 2024
Journal: Biochem Pharmacol
Title: Urocortin2 attenuates diabetic coronary microvascular dysfunction by regulating macrophage extracellular vesicles.
Volume: 219
Pages: 115976
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
Publication
First Author: Chen A
Year: 2006
Journal: J Neurosci
Title: Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior.
Volume: 26
Issue: 20
Pages: 5500-10
Publication
First Author: Chen A
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle.
Volume: 103
Issue: 44
Pages: 16580-5
Publication
First Author: Hsu SY
Year: 2001
Journal: Nat Med
Title: Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.
Volume: 7
Issue: 5
Pages: 605-11
Publication
First Author: Chen A
Year: 2005
Journal: Mol Endocrinol
Title: Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
Volume: 19
Issue: 2
Pages: 441-58
Publication
First Author: Reyes TM
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
Volume: 98
Issue: 5
Pages: 2843-8
Publication
First Author: Neufeld-Cohen A
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery.
Volume: 107
Issue: 44
Pages: 19020-5
Publication
First Author: Burns DP
Year: 2017
Journal: Exp Physiol
Title: Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.
Volume: 102
Issue: 9
Pages: 1177-1193
Publication
First Author: Reutenauer-Patte J
Year: 2012
Journal: Am J Pathol
Title: Urocortins improve dystrophic skeletal muscle structure and function through both PKA- and Epac-dependent pathways.
Volume: 180
Issue: 2
Pages: 749-62
Publication
First Author: Deussing JM
Year: 2010
Journal: J Neurosci
Title: Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2.
Volume: 30
Issue: 27
Pages: 9103-16
Publication
First Author: Lewis K
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
Volume: 98
Issue: 13
Pages: 7570-5
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2001
Title: Gene Ontology Annotation by the MGI Curatorial Staff
Publication        
First Author: GOA curators
Year: 2016
Title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2010
Title: Rat to Mouse ISO GO annotation transfer
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2002
Title: Chromosome assignment of mouse genes using the Mouse Genome Sequencing Consortium (MGSC) assembly and the ENSEMBL Database
Publication
First Author: Carninci P
Year: 2005
Journal: Science
Title: The transcriptional landscape of the mammalian genome.
Volume: 309
Issue: 5740
Pages: 1559-63
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2000
Title: Gene Ontology Annotation by electronic association of SwissProt Keywords with GO terms
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2010
Title: Human to Mouse ISO GO annotation transfer
Publication        
First Author: Marc Feuermann, Huaiyu Mi, Pascale Gaudet, Dustin Ebert, Anushya Muruganujan, Paul Thomas
Year: 2010
Title: Annotation inferences using phylogenetic trees
Publication      
First Author: Bairoch A
Year: 1999
Journal: Database Release
Title: SWISS-PROT Annotated protein sequence database
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and loading genome assembly coordinates from NCBI annotations
Publication      
First Author: Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI)
Year: 2010
Journal: Database Download
Title: Consensus CDS project
Publication      
First Author: Mouse Genome Informatics
Year: 2010
Journal: Database Release
Title: Protein Ontology Association Load.
Publication      
First Author: Mouse Genome Database and National Center for Biotechnology Information
Year: 2000
Journal: Database Release
Title: Entrez Gene Load
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform
Publication      
First Author: Mouse Genome Informatics Group
Year: 2003
Journal: Database Procedure
Title: Automatic Encodes (AutoE) Reference
Protein
Organism: Mus musculus/domesticus
Length: 123  
Fragment?: false
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Publication
First Author: Spyroglou A
Year: 2015
Journal: Endocrinology
Title: Adrenal and Ovarian Phenotype of a Tissue-Specific Urocortin 2-Overexpressing Mouse Model.
Volume: 156
Issue: 7
Pages: 2646-56
Allele
Name: gene trap ROSA 26, Philippe Soriano; targeted mutation 2, Jan Deussing
Allele Type: Targeted
Attribute String: Conditional ready, Inserted expressed sequence
Publication
First Author: Tsuda T
Year: 2017
Journal: J Exp Med
Title: Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction.
Volume: 214
Issue: 7
Pages: 1877-1888
Publication  
First Author: Meister J
Year: 2022
Journal: Mol Metab
Title: In vivo metabolic effects after acute activation of skeletal muscle Gs signaling.
Volume: 55
Pages: 101415
Publication
First Author: Giardino WJ
Year: 2011
Journal: Genes Brain Behav
Title: Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine.
Volume: 10
Issue: 1
Pages: 78-89
Publication
First Author: Arase S
Year: 2016
Journal: PLoS One
Title: Disturbance in the Mucosa-Associated Commensal Bacteria Is Associated with the Exacerbation of Chronic Colitis by Repeated Psychological Stress; Is That the New Target of Probiotics?
Volume: 11
Issue: 8
Pages: e0160736
Publication  
First Author: Bagosi Z
Year: 2018
Journal: Brain Res
Title: Anxiolytic- and antidepressant-like actions of Urocortin 2 and its fragments in mice.
Volume: 1680
Pages: 62-68
Publication
First Author: Vita N
Year: 1993
Journal: FEBS Lett
Title: Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors.
Volume: 335
Issue: 1
Pages: 1-5
Publication
First Author: Chen R
Year: 1993
Journal: Proc Natl Acad Sci U S A
Title: Expression cloning of a human corticotropin-releasing-factor receptor.
Volume: 90
Issue: 19
Pages: 8967-71
Publication
First Author: Hollenstein K
Year: 2013
Journal: Nature
Title: Structure of class B GPCR corticotropin-releasing factor receptor 1.
Volume: 499
Issue: 7459
Pages: 438-43
Publication
First Author: Yu J
Year: 1996
Journal: Endocrinology
Title: Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I.
Volume: 137
Issue: 1
Pages: 192-7
Publication
First Author: Lovenberg TW
Year: 1995
Journal: Proc Natl Acad Sci U S A
Title: Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.
Volume: 92
Issue: 3
Pages: 836-40
Publication
First Author: Liaw CW
Year: 1996
Journal: Endocrinology
Title: Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid.
Volume: 137
Issue: 1
Pages: 72-7
Protein Domain
Type: Family
Description: G protein-coupled receptors (GPCRs) constitute a vast protein family that encompasses a wide range of functions, including various autocrine, paracrine and endocrine processes. They show considerable diversity at the sequence level, on the basis of which they can be separated into distinct groups []. The term clan can be used to describe the GPCRs, as they embrace a group of families for which there are indications of evolutionary relationship, but between which there is no statistically significant similarity in sequence []. The currently known clan members include rhodopsin-like GPCRs (Class A, GPCRA), secretin-like GPCRs (Class B, GPCRB), metabotropic glutamate receptor family (Class C, GPCRC), fungal mating pheromone receptors (Class D, GPCRD), cAMP receptors (Class E, GPCRE) and frizzled/smoothened (Class F, GPCRF) [, , , , ]. GPCRs are major drug targets, and are consequently the subject of considerable research interest. It has been reported that the repertoire of GPCRs for endogenous ligands consists of approximately 400 receptors in humans and mice []. Most GPCRs are identified on the basis of their DNA sequences, rather than the ligand they bind, those that are unmatched to known natural ligands are designated by as orphan GPCRs, or unclassified GPCRs [].The secretin-like GPCRs include secretin [], calcitonin [], parathyroid hormone/parathyroid hormone-related peptides []and vasoactive intestinal peptide [], all of which activate adenylyl cyclase and the phosphatidyl-inositol-calcium pathway. These receptors contain seven transmembrane regions, in a manner reminiscent of the rhodopsins and other receptors believed to interact with G-proteins (however there is no significant sequence identity between these families, the secretin-like receptors thus bear their own unique '7TM' signature). Their N-terminal is probably located on the extracellular side of the membrane and potentially glycosylated. This N-terminal region contains a long conserved region which allows the binding of large peptidic ligand such as glucagon, secretin, VIP and PACAP; this region contains five conserved cysteines residues which could be involved in disulphide bond. The C-terminal region of these receptor is probably cytoplasmic. Every receptor gene in this family is encoded on multiple exons, and several of these genes are alternatively spliced to yield functionally distinct products. Corticotropin-releasing factor (CRF) is the principal neuroregulator of the hypothalamic-pituitary-adrenocortical axis, playing an important role in coordinating the endocrine, autonomic and behavioral responses to stress and immune challenge []. The CRF receptor has been found in human cortex tissue, pituitary, brainstem and testis []. The protein comprises 415 amino acid residues with the characteristic 7TM architecture of the secretin-like GPCR superfamily. Three isoforms (designated CRF-R1, CRF-R2 and CRF-R3) are produced as a result of alternative splicing of the same gene: CRF-R1 appears to be the predominant form; CRF-R3 does not bind to CRF with a high affinity []. CRF and the related urocortin peptides (Ucn 1-3, also known as UCN, UCN2 and UCN3) mediate their actions through two CRF1 and CRF2 [].
Protein Domain
Type: Family
Description: G protein-coupled receptors (GPCRs) constitute a vast protein family that encompasses a wide range of functions, including various autocrine, paracrine and endocrine processes. They show considerable diversity at the sequence level, on the basis of which they can be separated into distinct groups []. The term clan can be used to describe the GPCRs, as they embrace a group of families for which there are indications of evolutionary relationship, but between which there is no statistically significant similarity in sequence []. The currently known clan members include rhodopsin-like GPCRs (Class A, GPCRA), secretin-like GPCRs (Class B, GPCRB), metabotropic glutamate receptor family (Class C, GPCRC), fungal mating pheromone receptors (Class D, GPCRD), cAMP receptors (Class E, GPCRE) and frizzled/smoothened (Class F, GPCRF) [, , , , ]. GPCRs are major drug targets, and are consequently the subject of considerable research interest. It has been reported that the repertoire of GPCRs for endogenous ligands consists of approximately 400 receptors in humans and mice []. Most GPCRs are identified on the basis of their DNA sequences, rather than the ligand they bind, those that are unmatched to known natural ligands are designated by as orphan GPCRs, or unclassified GPCRs [].The secretin-like GPCRs include secretin [], calcitonin [], parathyroid hormone/parathyroid hormone-related peptides []and vasoactive intestinal peptide [], all of which activate adenylyl cyclase and the phosphatidyl-inositol-calcium pathway. These receptors contain seven transmembrane regions, in a manner reminiscent of the rhodopsins and other receptors believed to interact with G-proteins (however there is no significant sequence identity between these families, the secretin-like receptors thus bear their own unique '7TM' signature). Their N-terminal is probably located on the extracellular side of the membrane and potentially glycosylated. This N-terminal region contains a long conserved region which allows the binding of large peptidic ligand such as glucagon, secretin, VIP and PACAP; this region contains five conserved cysteines residues which could be involved in disulphide bond. The C-terminal region of these receptor is probably cytoplasmic. Every receptor gene in this family is encoded on multiple exons, and several of these genes are alternatively spliced to yield functionally distinct products. Corticotropin-releasing factor (CRF) is the principal neuroregulator of the hypothalamic-pituitary-adrenocortical axis, playing an important role in coordinating the endocrine, autonomic and behavioral responses to stress and immune challenge []. The CRF receptor has been found in human cortex tissue, pituitary, brainstem and testis []. The protein comprises 415 amino acid residues with the characteristic 7TM architecture of the secretin-like GPCR superfamily. Three isoforms (designated CRF-R1, CRF-R2 and CRF-R3) are produced as a result of alternative splicing of the same gene: CRF-R1 appears to be the predominant form; CRF-R3 does not bind to CRF with a high affinity []. CRF and the related urocortin peptides (Ucn 1-3, also known as UCN, UCN2 and UCN3) mediate their actions through two CRF1 and CRF2 [].The sequence of the CRF-R is highly conserved from avian to mammalian species, the majority of the sequence divergence occuring in the putativesignal peptide and extracellular N-terminal domain []. Five additional amino acids are inserted in the N terminus of the avian receptor, and despite its overall similarity to the type 1 mammalian CRF-R, its ligand binding properties are similar to those of the type 2 receptor (i.e., has a higher affinity for urotensin I than for CRF) []. This entry includes CRF1 receptor (CRF1R, also known as CRHR1), which is activated by CRF and Ucn1, is expressed in brain areas including the pituitary, hypothalamus, amygdala and cortex. It is an interesting target to develop drug treatments for stress-related conditions such as anxiety, depression and irritable bowel syndrome [].
Protein Domain
Type: Family
Description: G protein-coupled receptors (GPCRs) constitute a vast protein family that encompasses a wide range of functions, including various autocrine, paracrine and endocrine processes. They show considerable diversity at the sequence level, on the basis of which they can be separated into distinct groups []. The term clan can be used to describe the GPCRs, as they embrace a group of families for which there are indications of evolutionary relationship, but between which there is no statistically significant similarity in sequence []. The currently known clan members include rhodopsin-like GPCRs (Class A, GPCRA), secretin-like GPCRs (Class B, GPCRB), metabotropic glutamate receptor family (Class C, GPCRC), fungal mating pheromone receptors (Class D, GPCRD), cAMP receptors (Class E, GPCRE) and frizzled/smoothened (Class F, GPCRF) [, , , , ]. GPCRs are major drug targets, and are consequently the subject of considerable research interest. It has been reported that the repertoire of GPCRs for endogenous ligands consists of approximately 400 receptors in humans and mice []. Most GPCRs are identified on the basis of their DNA sequences, rather than the ligand they bind, those that are unmatched to known natural ligands are designated by as orphan GPCRs, or unclassified GPCRs [].The secretin-like GPCRs include secretin [], calcitonin [], parathyroid hormone/parathyroid hormone-related peptides []and vasoactive intestinal peptide [], all of which activate adenylyl cyclase and the phosphatidyl-inositol-calcium pathway. These receptors contain seven transmembrane regions, in a manner reminiscent of the rhodopsins and other receptors believed to interact with G-proteins (however there is no significant sequence identity between these families, the secretin-like receptors thus bear their own unique '7TM' signature). Their N-terminal is probably located on the extracellular side of the membrane and potentially glycosylated. This N-terminal region contains a long conserved region which allows the binding of large peptidic ligand such as glucagon, secretin, VIP and PACAP; this region contains five conserved cysteines residues which could be involved in disulphide bond. The C-terminal region of these receptor is probably cytoplasmic. Every receptor gene in this family is encoded on multiple exons, and several of these genes are alternatively spliced to yield functionally distinct products. Corticotropin-releasing factor (CRF) is the principal neuroregulator of the hypothalamic-pituitary-adrenocortical axis, playing an important role in coordinating the endocrine, autonomic and behavioral responses to stress and immune challenge []. The CRF receptor has been found in human cortex tissue, pituitary, brainstem and testis []. The protein comprises 415 amino acid residues with the characteristic 7TM architecture of the secretin-like GPCR superfamily. Three isoforms (designated CRF-R1, CRF-R2 and CRF-R3) are produced as a result of alternative splicing of the same gene: CRF-R1 appears to be the predominant form; CRF-R3 does not bind to CRF with a high affinity []. CRF and the related urocortin peptides (Ucn 1-3, also known as UCN, UCN2 and UCN3) mediate their actions through two CRF1 and CRF2 [].For the CRF-R2 receptor, at least 2 splice forms with different 5'-coding sequences (CRF2 alpha and CRF2 beta) have been identified in rat []. The sequence of the CRF-R is highly conserved between species, the majority of the sequence divergence occuring in the putative signal peptide and extracellular N-terminal domain. The relative abundance of CRF-R2 messenger RNA appears to be lower in humans than in rats for the heart and skeletal tissues studied to date []. CRF-R2 stimulates cAMP production in response to CRF and known CRF-like agonists []. CRF and the non-mammalian CRF-related peptides sauvagine and urotensin I stimulate adenylate cyclaseactivity in a dose-dependent manner, with a rank order of potency thatdiffers from that of the CRF1 receptor (sauvagine>urotensin>=rat/human CRF>ovine CRF). The differences in the pharmacological profiles and tissue distributions of CRF-R1 and CRF-R2 suggests important functionaldifferences between the two receptors [].
Protein
Organism: Mus musculus/domesticus
Length: 82  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 143  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 375  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 64  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 210  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 415  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 411  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 410  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 420  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 431  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 420  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 415  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 430  
Fragment?: false
Publication
First Author: Ishihara T
Year: 1991
Journal: EMBO J
Title: Molecular cloning and expression of a cDNA encoding the secretin receptor.
Volume: 10
Issue: 7
Pages: 1635-41
Publication
First Author: Ishihara T
Year: 1992
Journal: Neuron
Title: Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.
Volume: 8
Issue: 4
Pages: 811-9
Publication
First Author: Lin HY
Year: 1991
Journal: Science
Title: Expression cloning of an adenylate cyclase-coupled calcitonin receptor.
Volume: 254
Issue: 5034
Pages: 1022-4
Publication
First Author: Jüppner H
Year: 1991
Journal: Science
Title: A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide.
Volume: 254
Issue: 5034
Pages: 1024-6
Publication
First Author: Vassilatis DK
Year: 2003
Journal: Proc Natl Acad Sci U S A
Title: The G protein-coupled receptor repertoires of human and mouse.
Volume: 100
Issue: 8
Pages: 4903-8
Publication
First Author: Attwood TK
Year: 1994
Journal: Protein Eng
Title: Fingerprinting G-protein-coupled receptors.
Volume: 7
Issue: 2
Pages: 195-203
Publication
First Author: Kolakowski LF Jr
Year: 1994
Journal: Receptors Channels
Title: GCRDb: a G-protein-coupled receptor database.
Volume: 2
Issue: 1
Pages: 1-7
Publication
First Author: Foord SM
Year: 2005
Journal: Pharmacol Rev
Title: International Union of Pharmacology. XLVI. G protein-coupled receptor list.
Volume: 57
Issue: 2
Pages: 279-88
Publication
First Author: Harmar AJ
Year: 2009
Journal: Nucleic Acids Res
Title: IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels.
Volume: 37
Issue: Database issue
Pages: D680-5